In situ modeling of acquired resistance to RTK/RAS pathway targeted therapies is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2023). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01CA255232-02
Isoform-specific signaling as a determinant of RAS-driven oncogenesis
National Institutes of Health
Grant: 5R21CA267515-02
Preventing Therapeutic Resistance in RAS-mutated Pediatric Cancers
Fields of Study
Keywords